| Literature DB >> 30311420 |
Marília Miotto1, Sylvia A Ossai2, Joan E Meredith2, Clarissa Barretta1, Airton Kist3, Elane S Prudencio1, Cleide R W Vieira1, Salina Parveen2.
Abstract
The aim of this study was to determine the serogroups, antimicrobial resistance and genetic diversity of Escherichia coli isolates from samples of bivalve mollusks collected along Santa Catarina coast, Brazil, and from the Chesapeake Bay, Maryland, USA. One hundred forty-one E. coli isolates were characterized for serogroups with 181 specific O antisera and antimicrobial susceptibility using the disk diffusion method. The genetic diversity was assessed using pulsed-field gel electrophoresis (PFGE). The results showed that among the isolates, 19.9% were classified as multi-drug resistant (MDR) and resistance was most frequently observed to cephalothin, nitrofurantoin, and ampicillin. The predominant serogroups were O6, O8, and O38. Some serogroups were recognized as pathogenic E. coli. PFGE dendrograms indicated extensive genetic diversity among the isolates. Although characteristics of the E. coli isolates were highly variable, it is important to note that E. coli belonging to pathogenic serogroups and MDR isolates are present in mollusks of both study areas. This is the first report on the phenotypic and genotypic characterization of E. coli from mollusks from Santa Catarina and the Chesapeake Bay that should encourage studies focusing on comparison of isolates across countries.Entities:
Keywords: zzm321990Escherichia colizzm321990; pulsed-field gel electrophoresis; resistance; serogrouping; shellfish
Mesh:
Year: 2018 PMID: 30311420 PMCID: PMC6528596 DOI: 10.1002/mbo3.738
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
Percentages of antimicrobial resistance and intermediate resistance determined by the disk diffusion method in Escherichia coli isolates from mollusks samples from Brazil and the United States
| Antimicrobial | Brazil ( | United States ( | Total ( | |||
|---|---|---|---|---|---|---|
| Resistant | Intermediate | Resistant | Intermediate | Resistant | Intermediate | |
| KF | 73.0 | 26.0 | 90.2 | 9.8 | 78.0 | 21.3 |
| FM | 12.0 | 46.0 | 43.9 | 48.8 | 21.3 | 46.8 |
| AM | 19.0 | 49.0 | 22.0 | 53.7 | 19.9 | 50.4 |
| TE | 16.0 | 2.0 | 0 | 0 | 11.3 | 1.4 |
| FOX | 0 | 4.0 | 31.7 | 12.2 | 9.2 | 6.4 |
| SXT | 9.0 | 2.0 | 0 | 2.4 | 6.4 | 2.1 |
| NA | 6.0 | 24.0 | 4.9 | 22.0 | 5.7 | 23.4 |
| AMC | 0 | 40.0 | 19.5 | 53.7 | 5.7 | 44.0 |
| CRO | 5.0 | 25.0 | 2.4 | 17.1 | 4.3 | 22.7 |
| AN | 2.0 | 17.0 | 0 | 43.9 | 1.4 | 24.8 |
| GM | 1.0 | 6.0 | 2.4 | 24.4 | 1.4 | 11.3 |
| CIP | 1.0 | 11.0 | 0 | 24.4 | 0.7 | 14.9 |
| C | 1.0 | 5.0 | 0 | 0 | 0.7 | 3.5 |
| FEP | 1.0 | 0 | 0 | 0 | 0.7 | 0 |
| NOR | 1.0 | 3.0 | 0 | 0 | 0.7 | 2.1 |
AM: ampicillin; AMC: amoxicillin/clavulanic acid; AN: amikacin; C: chloramphenicol; CIP: ciprofloxacin; CRO: ceftriaxone; FEP: cefepime; FM: nitrofurantoin; FOX: cefoxitin; GM: gentamicin; KF: cephalothin; NA: nalidixic acid; NOR: norfloxacin; SXT: trimethoprim/sulfamethoxazole; TE: tetracycline.
Antimicrobial resistance profiles determined by the disk diffusion method of Escherichia coli isolates from mollusks samples from Brazil and US samples
| Resistance profile | Number (%) of isolates in samples from: | ||
|---|---|---|---|
| Brazil ( | United States ( | Total ( | |
| KF‐AM‐SXT‐TE‐NOR‐NA‐C | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM‐SXT‐TE‐CRO‐FM | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM‐SXT‐TE‐CRO | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM‐SXT‐TE‐FM | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM‐FM‐FOX‐AMC | 0 | 2 (4.9) | 2 (1.4) |
| KF‐AM‐FM‐TE‐NA | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM‐FM‐TE | 2 (2.0) | 0 | 2 (1.4) |
| KF‐AM‐FOX‐AMC | 0 | 4 (9.8) | 4 (2.8) |
| KF‐AM‐FOX‐CRO | 0 | 1 (2.4) | 1 (0.7) |
| KF‐SXT‐AM‐TE | 1 (1.0) | 0 | 1 (0.7) |
| KF‐SXT‐TE‐CRO | 1 (1.0) | 0 | 1 (0.7) |
| KF‐FM‐FOX‐AMC | 0 | 2 (4.9) | 2 (1.4) |
| KF‐FM‐NA | 1 (1.0) | 2 (4.9) | 3 (2.1) |
| KF‐AM‐TE | 2 (2.0) | 0 | 2 (1.4) |
| KF‐AM‐FOX | 0 | 1 (2.4) | 1 (0.7) |
| KF‐AM‐AN | 1 (1.0) | 0 | 1 (0.7) |
| KF‐GM‐FM | 1 (1.0) | 1 (2.4) | 2 (1.4) |
| KF‐CRO‐AM | 1 (1.0) | 0 | 1 (0.7) |
| CRO‐TE‐NA | 1 (1.0) | 0 | 1 (0.7) |
| SXT‐TE‐AM | 1 (1.0) | 0 | 1 (0.7) |
| SXT‐TE‐KF | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AM | 6 (6.0) | 1 (2.4) | 7 (5.0) |
| KF‐FM | 2 (2.0) | 10 (24.4) | 12 (8.5) |
| KF‐CIP | 1 (1.0) | 0 | 1 (0.7) |
| KF‐AN | 1 (1.0) | 0 | 1 (0.7) |
| KF‐FOX | 0 | 2 (4.9) | 2 (1.4) |
| KF‐NA | 2 (2.0) | 0 | 2 (1.4) |
| KF‐TE | 2 (2.0) | 0 | 2 (1.4) |
| KF‐SXT | 1 (1.0) | 0 | 1 (0.7) |
| FM‐FOX | 0 | 1 (2.4) | 1 (0.7) |
| FM‐FEP | 1 (1.0) | 0 | 1 (0.7) |
| FM | 2 (2.0) | 0 | 2 (1.4) |
| KF | 42 (42.0) | 11 (26.8) | 53 (37.6) |
AM: ampicillin; AMC: amoxicillin/clavulanic acid; AN: amikacin; C: chloramphenicol; CIP: ciprofloxacin; CRO: ceftriaxone; FEP: cefepime; FM: nitrofurantoin; FOX: cefoxitin; GM: gentamicin; KF: cephalothin; NA: nalidixic acid; NOR: norfloxacin; SXT: trimethoprim/sulfamethoxazole; TE: tetracycline.
MDR profiles.
O‐serogroups of Escherichia coli isolates from mollusks samples from Brazil and US samples
| O‐Serogroups | Number (%) of | |
|---|---|---|
| Brazil ( | USA ( | |
| 6 | 7 (7) | 2 (4.9) |
| 9 | 2 (2) | 4 (9.8) |
| 25 | 1 (1) | 2 (4.9) |
| 54 | 1 (1) | 2 (4.9) |
| 88 | 2 (2) | 1 (2.4) |
| 113 | 1 (1) | 4 (9.8) |
| 8 | 17 (17) | 0 |
| 20 | 0 | 3 (7.3) |
| 21 | 4 (4) | 0 |
| 38 | 0 | 11 (26.8) |
| 37 | 2 (2) | 0 |
| 45 | 2 (2) | 0 |
| 85 | 2 (2) | 0 |
| 86 | 2 (2) | 0 |
| 91 | 2 (2) | 0 |
| 93 | 0 | 2 (4.9) |
| 126 | 2 (2) | 0 |
| 139 | 2 (2) | 0 |
| 159 | 2 (2) | 0 |
| 175 | 3 (3) | 0 |
| 180 | 2 (2) | 0 |
| (107, 177) | 1 (1) | 0 |
| (17, 73, 77, 106) | 4 (4) | 0 |
| (5, 11, 12, 15, 23, 33, 40, 59, 75, 82, 96, 105, 112, 128, 146, 148, 150, 163, 166, 176) | 20 (20) | 0 |
| (7, 64) | 0 | 2 (4.9) |
| M | 7 (7) | 3 (7.3) |
| N | 12 (12) | 5 (12.2) |
M: reacted with antisera of several serogroups; N: did not react with any known O groups.
Serogroups that were identified in the same isolate.
Serogroups that contained only one isolate (Brazil).
Serogroups that contained only one isolate (USA).
Figure 1Dendrogram of PFGE patterns of Escherichia coli isolated from mollusks harvested in Brazil and the United States. AM: ampicillin; AMC: amoxicillin/clavulanic acid; AN: amikacin; C: chloramphenicol; CIP: ciprofloxacin; CRO: ceftriaxone; FEP: cefepime; FM: nitrofurantoin; FOX: cefoxitin; GM: gentamicin; KF: cephalotin; NA: nalidixic acid; NOR: norfloxacin; SXT: trimethoprim/sulfamethoxazole; TE: tetracycline; (−): not resistant; M: reacted with antisera of several serogroups; N: did not react with any known O groups; C1 to C37: identification of the clusters considering 80% similarity